von Wrede, Randi
Helmstaedter, Christoph
Surges, Rainer
Funding for this research was provided by:
Projekt DEAL
Article History
Accepted: 15 January 2021
First Online: 9 February 2021
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL.
: Randi von Wrede has received fees as a speaker, consultant, or travel support from Cerbomed, Desitin, GW Pharmaceuticals, Eisai, and UCB. Christoph Helmstaedter has received grants from the European Union, travel support from Desitin, honoraria for lectures, counseling, and advisory boards from GW Pharmaceuticals, EISAI, and UCB, as well as license fees from EISAI and UCB. Rainer Surges has received fees as a speaker or consultant from Bial, Cyberonics, Desitin, EISAI, LivaNova, Novartis, and UCB Pharma, and grants from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), the Bundesministerium für Gesundheit, and the Marga and Walter Boll Stiftung.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: RvW; writing, original draft preparation: RvW, CH; writing, review, and editing: RvW, CH, RS; supervision: RvW, RS.